Literature DB >> 25886681

Who pioneered the use of antipsychotics in North America?

Emmanuel Stip1.   

Abstract

OBJECTIVE: Neuroleptics were introduced into North America 60 years ago. The credit for this advance is generally accorded to Heinz Lehmann. I sought to explore whether Lehmann really was the first North American psychiatrist to study the effects of chlorpromazine (CPZ) and to provide a more balanced view of its application in a clinical context.
METHOD: I searched for historical documents and published articles in several libraries and interviewed psychiatrists active from 1952-1970.
RESULTS: The first article in English was published in the July volume of the Archives of Neurology and Psychiatry in 1954 (n=71). Another article, written in French by Roland Saucier and published in a journal called Le Saguenay Médical, also described the effects of CPZ on a Canadian psychiatric population in August 1954 (n>200). However, the first prescription for CPZ was written by Roland Saucier, who brought the product back from Paris after a fellowship there. Ruth Kajander, in Ontario, was also one of the first prescribers of this drug, following her study of its use in anesthesia and a publication in the proceedings of a symposium.
CONCLUSION: The contents of the 2 naturalistic studies were compared. Lehmann's study started 1 month before that of Saucier. Lehmann was the first North American psychiatrist to publish an article on CPZ, but Roland Saucier nevertheless made an important contribution, being the first to prescribe this drug in North America and reporting results for a study with a sample size 3 times that of Lehmann's study.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25886681      PMCID: PMC4418623     

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  35 in total

1.  Happy birthday neuroleptics! 50 years later: la folie du doute.

Authors:  Emmanuel Stip
Journal:  Eur Psychiatry       Date:  2002-05       Impact factor: 5.361

2.  Largactil in psychiatry.

Authors:  R R WEBB
Journal:  Med J Aust       Date:  1955-05-21       Impact factor: 7.738

3.  Effect of chlorpromazine on the behavior of chronically overactive psychotic patients.

Authors:  J ELKES; C ELKES
Journal:  Br Med J       Date:  1954-09-04

4.  [Therapeutic method derived from hiberno-therapy in excitation and agitation states].

Authors:  J DELAY; P DENIKER; J M HARL
Journal:  Ann Med Psychol (Paris)       Date:  1952-07       Impact factor: 0.380

5.  Treatment of manic psychoses with antihistamine drugs.

Authors:  O R BRYANT
Journal:  Am Pract Dig Treat       Date:  1950-02

6.  [Malariatherapy in Italy. A historical account of therapeutic inoculation of malaria parasites in Italian psychiatric clinics].

Authors:  Alessandra Bonfigli; Edvige Fanfera; Gilberto Corbellini
Journal:  Med Secoli       Date:  2004

Review 7.  Pharmacotherapy of mental illness--a historical analysis.

Authors:  T A Ban
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2001-05       Impact factor: 5.067

8.  Antibacterial effect of some phenothiazine compounds and R-factor elimination by chlorpromazine.

Authors:  J Molnár; Y Mándi; J Király
Journal:  Acta Microbiol Acad Sci Hung       Date:  1976

9.  Therapeutic results with chlorpromazine (largactil) in psychiatric conditions.

Authors:  H E LEHMANN
Journal:  Can Med Assoc J       Date:  1955-01-15       Impact factor: 8.262

10.  Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the Worldwide Schizophrenia Outpatients Health Outcomes (W-SOHO) study.

Authors:  Jihyung Hong; Diego Novick; Roberto Brugnoli; Jamie Karagianis; Martin Dossenbach; Josep Maria Haro
Journal:  BMC Psychiatry       Date:  2012-12-04       Impact factor: 3.630

View more
  4 in total

1.  The 10th Anniversary of the Eli Lilly Chair of Schizophrenia from the University of Montreal.

Authors:  Emmanuel Stip; Stéphane Potvin
Journal:  Can J Psychiatry       Date:  2015-03       Impact factor: 4.356

2.  Use of long acting antipsychotics and relationship to newly diagnosed bipolar disorder: a pragmatic longitudinal study based on a Canadian health registry.

Authors:  Emmanuel Stip; Syed Javaid; Jonathan Bayard-Diotte; Karim Abdel Aziz; Danilo Arnone
Journal:  Ther Adv Psychopharmacol       Date:  2020-09-13

3.  Learning soft skills the hard way: Historiographical considerations on the cultural adjustment process of German-speaking émigré neuroscientists in Canada, 1933 to 1963.

Authors:  Frank W Stahnisch
Journal:  J Hist Neurosci       Date:  2016-01-21       Impact factor: 0.529

4.  Infra-Low Frequency Neurofeedback rapidly ameliorates schizophrenia symptoms: A case report of the first session.

Authors:  Joannis N Nestoros; Nionia G Vallianatou
Journal:  Front Hum Neurosci       Date:  2022-09-21       Impact factor: 3.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.